Valuation: Cipla Limited

Market Cap 1,114B 11.73B 10.52B 9.68B 8.76B 16.39B 16.71B 115B 46.36B 586B 44.04B 43.09B 1,849B P/E 2027 *
28.3x
P/E 2028 * 22.2x
Enterprise Value 1,017B 10.71B 9.6B 8.83B 8B 14.96B 15.26B 105B 42.33B 535B 40.21B 39.34B 1,688B EV / Sales 2027 *
3.33x
EV / Sales 2028 * 2.84x
Free-Float
68.87%
Yield 2027 *
0.91%
Yield 2028 * 1.03%
1 day+1.54%
1 week+3.06%
1 month+2.44%
3 months-6.40%
6 months+5.29%
Current year-8.76%
1 week 1,319
Extreme 1319
1,381.7
1 month 1,292
Extreme 1292
1,381.7
Current year 1,165.7
Extreme 1165.7
1,539.7
1 year 1,165.7
Extreme 1165.7
1,539.7
3 years 1,164.55
Extreme 1164.55
1,702.05
5 years 850
Extreme 850
1,702.05
10 years 355.3
Extreme 355.3
1,702.05
Manager TitleAgeSince
Chief Executive Officer - 2026-03-31
Director of Finance/CFO - 2026-07-23
President - 2026-05-17
Director TitleAgeSince
Chairman 90 1972-07-20
Director/Board Member 72 2014-07-24
Director/Board Member 71 2021-06-29
Date Insider Type Main position Quantity % Market Cap. Importance
8/22/24 Sell 2,000 0.0002%
8/14/24 Sell 3,000 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
+1.54%+3.06%-8.15%+14.91% 11.73B
+3.19%+11.31%+64.28%+155.91% 1,263B
-0.73%+3.56%+44.65%+84.17% 658B
+1.41%+3.24%+35.25%+108.88% 521B
+0.42%+3.20%+55.81%+72.50% 391B
+2.18%+2.93%+73.90%+45.59% 369B
+1.12%+4.52%+34.76%+58.24% 307B
+6.96%+8.86%+11.95%+36.20% 290B
+1.15%+6.09%+56.15%+82.25% 252B
+3.06%+9.38%+42.48%+117.32% 212B
Average +2.03%+5.62%+41.11%+77.60% 427.37B
Weighted average by Cap. +2.01%+6.59%+50.35%+100.20%

Financials

2027 *2028 *
Net sales 306B 3.22B 2.89B 2.65B 2.4B 4.5B 4.59B 31.58B 12.72B 161B 12.08B 11.82B 507B 346B 3.65B 3.27B 3.01B 2.72B 5.09B 5.19B 35.76B 14.4B 182B 13.68B 13.39B 574B
Net income 39.25B 413M 371M 341M 309M 577M 589M 4.06B 1.63B 20.65B 1.55B 1.52B 65.14B 50.29B 530M 475M 437M 396M 740M 754M 5.2B 2.09B 26.45B 1.99B 1.95B 83.45B
Net Debt -96.77B -1.02B -913M -840M -761M -1.42B -1.45B -10B -4.03B -50.91B -3.83B -3.74B -161B -130B -1.37B -1.23B -1.13B -1.02B -1.91B -1.95B -13.41B -5.4B -68.28B -5.13B -5.02B -215B
Projected Income Statement - Annual - Cipla Limited
Logo Cipla Limited
Cipla specializes in development, manufacturing and marketing of pharmaceutical products. The group provides prescription products and OTC medicines for the treatment of cardiovascular, ophthalmic and dermatological diseases, respiratory troubles, cancers, allergies, infections etc. Besides, Cipla develops and sells veterinary products. Net sales by source of income break down between sale of products (96.9%) and services (3.1%). Net sales are distributed geographically as follows: India (39.4%), the United States (18.5%), South Africa (17%) and other (25.1%).
Employees
31,369
Date Price Change Volume
26-10-30 ₹1,378.90 +1.54% 1,436,661
26-10-29 ₹1,358.00 -0.56% 1,141,230
26-10-28 ₹1,365.60 +1.16% 997,121
26-10-27 ₹1,350.00 -0.37% 4,078,811
26-10-26 ₹1,355.00 +1.27% 1,548,428
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Cipla Limited
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
36
Last Close Price
1,378.90INR
Average target price
1,508.83INR
Spread / Average Target
+9.42%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Cipla Limited
  1. Stock Market
  2. Stocks
  3. CIPLA Stock